Arficus introduces MEDHINI, the world's first Generative AI-based Software as a Medical Device (SaMD), designed to revolutionize healthcare diagnostics. MEDHINI offers rapid, accurate, and affordable diagnostic solutions across multiple medical specialties, including neurology, nephrology, cardiology, oncology, and pulmonology. By leveraging advanced deep-tech computer vision and natural language processing, MEDHINI achieves a clinical accuracy of 99.31%, reducing disease diagnosis time to just 53 seconds and costs to less than $7, even in remote areas globally.
Key Features and Functionality:
- Multi-Specialty Diagnostics: MEDHINI provides diagnostic capabilities across various medical fields, including neurology, nephrology, cardiology, oncology, and pulmonology.
- Rapid and Accurate Results: Utilizing advanced AI algorithms, MEDHINI delivers diagnoses with 99.31% clinical accuracy in under a minute.
- Cost-Effective Solutions: The platform reduces diagnostic costs to less than $7, making healthcare more accessible.
- Non-Invasive Integration: MEDHINI seamlessly integrates with existing medical equipment, such as X-rays, CT scans, and ultrasounds, without direct patient contact.
- Predictive Health Mapping: The system offers predictive triage for over 345 diseases, forecasting potential occurrences or recurrences over a five-year span based on current health data.
- Virtual Clinical Trials: MEDHINI supports in-silico virtual clinical trials, including bioavailability/bioequivalence (BA/BE) studies and antimicrobial resistance (AMR) analysis, enhancing drug discovery and efficacy assessments.
Primary Value and User Solutions:
MEDHINI addresses critical challenges in healthcare by providing rapid, accurate, and affordable diagnostic solutions, particularly benefiting underserved and remote communities. Its integration with existing medical infrastructure ensures minimal disruption while enhancing diagnostic capabilities. The platform's predictive health mapping aids in early disease detection and prevention, improving patient outcomes. Additionally, MEDHINI's support for virtual clinical trials accelerates drug development processes, contributing to more efficient and effective healthcare solutions worldwide.
